Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra P Wolanskyj

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Blood Cancer Journal|January 18, 2024
One thousand patients with essential thrombocythemia: the Mayo Clinic experienceNaseema Gangat, Omer Karrar, Aref Al-Kali, et al.
Cancer|April 19, 2007
Clinical correlates of JAK2V617F allele burden in essential thrombocythemiaJaya Kittur, Ryan A Knudson, Terra L Lasho, et al.
European Journal of Haematology|June 4, 2014
Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis historyNaseema Gangat, Emnet A Wassie, Terra L Lasho, et al.
European Journal of Haematology|April 16, 2024
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomesJordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, et al.
American Journal of Hematology|September 26, 2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelideAyalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, et al.
Leukemia Research|July 18, 2018
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblastsAbhishek A Mangaonkar, Naseema Gangat, Aref Al-Kali, et al.
Blood Advances|March 10, 2022
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular eventsNaseema Gangat, Natasha Szuber, Yamna Jadoon, et al.
European Journal of Haematology|October 26, 2011
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapyMichelle A Elliott, Louis Letendre, Ayalew Tefferi, et al.
Mayo Clinic Proceedings|March 3, 2024
Academic Promotions in Medicine: An Appraisal of FairnessRahma Warsame, Yong-Hun Kim, Melody Y Ouk, et al.
British Journal of Haematology|October 31, 2017
Efficacy of biological agents in the treatment of Erdheim-Chester diseaseGaurav Goyal, Mithun V Shah, Timothy G Call, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Blood Cancer Journal|January 18, 2024
One thousand patients with essential thrombocythemia: the Mayo Clinic experienceNaseema Gangat, Omer Karrar, Aref Al-Kali, et al.
Cancer|April 19, 2007
Clinical correlates of JAK2V617F allele burden in essential thrombocythemiaJaya Kittur, Ryan A Knudson, Terra L Lasho, et al.
European Journal of Haematology|June 4, 2014
Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis historyNaseema Gangat, Emnet A Wassie, Terra L Lasho, et al.
European Journal of Haematology|April 16, 2024
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomesJordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, et al.
American Journal of Hematology|September 26, 2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelideAyalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, et al.
Leukemia Research|July 18, 2018
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblastsAbhishek A Mangaonkar, Naseema Gangat, Aref Al-Kali, et al.
Blood Advances|March 10, 2022
1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular eventsNaseema Gangat, Natasha Szuber, Yamna Jadoon, et al.
European Journal of Haematology|October 26, 2011
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapyMichelle A Elliott, Louis Letendre, Ayalew Tefferi, et al.
Mayo Clinic Proceedings|March 3, 2024
Academic Promotions in Medicine: An Appraisal of FairnessRahma Warsame, Yong-Hun Kim, Melody Y Ouk, et al.
British Journal of Haematology|October 31, 2017
Efficacy of biological agents in the treatment of Erdheim-Chester diseaseGaurav Goyal, Mithun V Shah, Timothy G Call, et al.
Pageof 8